Search

everythinglearnresearchcommunity

for

Search:↓

Topical procyanidin B2 significantly increases hair count and is a safe treatment for male pattern baldness.

Type 2 diabetes, bacterial scalp infections, and tight hairstyles like braids and weaves are linked to a higher risk of a scarring hair loss condition in African American women.

Finasteride treats baldness but may cause lasting sexual side effects.

Men can have genetic risks for PCOS-related traits like obesity and diabetes.

New treatment improves male hair loss.

58% of men aged 30-50 have hair loss, with severity increasing with age.

Scalp reduction can improve hair distribution in certain baldness cases but requires careful patient selection and understanding of facial structure.

Excessive androgen in women can cause acne, hair growth, baldness, and PCOS, often treatable with medication.

Fibrosing alopecia in a pattern distribution is a type of hair loss that may often be overlooked, especially in men.

The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.

PCOS is a condition causing irregular periods, excess male hormones, and infertility, often managed by targeting insulin resistance and specific symptoms.

The patient with total hair loss did not regrow hair despite treatment, indicating a poor outlook for this type of hair loss.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

CBD may help reduce stress and pain in women with PCOS.

β-sitosterol and brassicasterol may help treat hair loss.

PCOS causes menstrual issues, infertility, and long-term health risks.

Immune changes and specific genes contribute to male hair loss.

Acne severity is not related to the type or severity of androgenetic alopecia.

PCOS is linked to metabolic issues and infertility, needing more research.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

The conclusion is that the current treatment for hair loss works well for most patients, but better results could be achieved by also focusing on patients' other health issues and habits.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

Andropause is strongly associated with hair loss in male civil servants.

Skin changes throughout life, from development before birth to aging effects like wrinkles, influenced by both genetics and environment.

The BASP classification is more reliable than the Norwood-Hamilton for classifying hair loss in men and women.

Botulinum toxin-A injections in the scalp can reduce hair loss and promote new hair growth in men with certain types of baldness.

Female pattern hair loss is common, worsens with age, and requires long-term treatment to manage.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Hair loss increases between July and October, possibly due to UV light, and factors like skin type, hair color, and density may affect this. Dandruff can worsen hair loss conditions.